Clinical trial
A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated…
NCT00310271 · PowderMed, Industry · Completed
Key facts
| NCT number | NCT00310271 |
|---|---|
| Title | A Safety Study to Assess a DNA Vaccine Administered by Particle Mediated Delivery to the Skin in Healthy Subjects |
| Official title | A Phase I Study Assessing Safety and Tolerability of a DNA Vaccine With a DNA Encoded Immunostimulator , Administered by Particle Mediated Epidermal Delivery Using the PowderMed ND10 Delivery System in HSV-2 Seronegative Healthy Volunteers |
| Lead sponsor | PowderMed, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HSV-2 |
| Intervention type | Biological |
| Interventions | pPJV7630 with pPJV2012 administered by PMED |
| Enrollment | 42 |
| Start date | Apr 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Apr 3, 2006 |
| Last update posted | Nov 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: